2-(3-Isopropyl-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No.: 
ACMXLG800
CAS No.: 
2121513-08-2
Molecular Formula: 
C16H25BO3
Molecular Weight: 
276.18
2-(3-Isopropyl-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$330.00InquiryInquiry
250mg97%$524.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Isopropyl-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(3-isopropyl-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC16H25BO3
Molecular Weight276.18
SMILESCOC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1C(C)C
InChI KeyJMHICHZKMJMOTN-UHFFFAOYSA-N
Synonym4-Methoxy-3-(1-methylethyl)phenylboronic acid pinacol ester;1,3,2-Dioxaborolane, 2-[4-methoxy-3-(1-methylethyl)phenyl]-4,4,5,5-tetramethyl-
CAS No.2121513-08-2

Synthetic Route by SureRoute

1. ACMXLG800 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMXLG800 route product structure diagram
    ACMXLG8002121513-08-2
Inquiry

2. ACMXLG800 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMXLG800 route product structure diagram
    ACMXLG8002121513-08-2
Inquiry

3. ACMXLG800 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMXLG800 route product structure diagram
    ACMXLG8002121513-08-2
Inquiry

Comments (0)